Related Articles
April 23, 2012
CEO Matthew Weinberg Presents at FDA Clinical Trials Hearing
April 23 - The Weinberg Group CEO, Matthew Weinberg, presented today at FDA’s hearing titled “Modernizing the Regulation of Clinical Trials and Approaches to Good Clinical Practice.” Mr. Weinberg...
February 11, 2014
Drug Companies Face Stricter Clinical Trial Regulation Worldwide
For more information on The Weinberg Group’s independent clinical auditing services, please contact Jeff Antos at jeff.antos@weinberggroup.com or 202.280.0815.
November 25, 2014
Matthew Weinberg Quoted in Article about EMA’s Initiative to Broaden Expert Involvement with Updated Policy on Conflicts of Interest
FDANews Drug Industry Daily Nov. 21, 2014 Europe’s drug regulatory agency has revised the conflict of interest policy for its scientific committee members and experts, a move that one attorney says...